VEGFA and age-related macular degeneration: Anti-VEGF therapy has become the standard treatment for improving visual acuity; however, a large percentage of patients suffer from poor visual prognosis because of subretinal fibrosis.5, 6 Therefore, alternative therapeutic approaches, which can attenuate both CNV and subretinal fibrosis formation, would fulfill an unmet medical need in the treatment of AMD.